0001209191-18-038946.txt : 20180621
0001209191-18-038946.hdr.sgml : 20180621
20180621162443
ACCESSION NUMBER: 0001209191-18-038946
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180619
FILED AS OF DATE: 20180621
DATE AS OF CHANGE: 20180621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldman Steven M.
CENTRAL INDEX KEY: 0001568216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 18912077
MAIL ADDRESS:
STREET 1: C/O DOVA PHARMACEUTICALS, INC.
STREET 2: 240 LEIGH FARM ROAD, SUITE 245
CITY: DURHAM
STATE: NC
ZIP: 27707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dova Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001685071
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813858961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2530 MERIDIAN PARKWAY
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919-806-4487
MAIL ADDRESS:
STREET 1: 2530 MERIDIAN PARKWAY
STREET 2: SUITE 300
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-19
0
0001685071
Dova Pharmaceuticals, Inc.
DOVA
0001568216
Goldman Steven M.
C/O DOVA PHARMACEUTICALS, INC.
240 LEIGH FARM ROAD, SUITE 245
DURHAM
NC
27707
1
0
0
0
Stock Option (Right to Buy)
30.11
2018-06-19
4
A
0
10000
0.00
A
2028-06-19
Common Stock
10000
10000
D
The shares subject to the option will vest in equal monthly installments over the 12 months commencing on July 19, 2018, provided that the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
/s/Darren DeStefano, Attorney-in-Fact
2018-06-21